explore -WSS

explore

author：fashion 2025-09-30 17:28:10 - browse：35

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

WSS

New documents shed light on MD Anderson Cancer Institute feud

R1 RCM gets $5.8 billion buyout offer from private equity firm

New documents shed light on MD Anderson Cancer Institute feud

Alabama frozen embryo ruling has major implications for IVF clinics

California Joshua trees severely burned in massive wildfire

In utero gene editing: an explainer

focus

explore

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

STAT readers on older presidents, polypills, Medicare, and more

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

What does generative AI mean for health care? We asked experts

Lifetime voting ban for felony convictions struck down in Mississippi

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Pharma needs to include young adults in clinical research

hotspot

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Pharma needs to include young adults in clinical research

Pediatricians' group reaffirms support for gender

Antivenom research: Lessons from HIV applied in search for universal antidote

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

knowledge

Wikipedia

entertainment

focus